SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

por Boulay, J-L, Mild, G, Lowy, A, Reuter, J, Lagrange, M, Terracciano, L, Laffer, U, Herrmann, R, Rochlitz, C
Publicado 2002

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

por Boulay, J-L, Mild, G, Lowy, A, Reuter, J, Lagrange, M, Terracciano, L, Laffer, U, Herrmann, R, Rochlitz, C
Publicado 2003

Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer

por Mamot, C, Mild, G, Reuter, J, Laffer, U, Metzger, U, Terracciano, L, Boulay, J-L, Herrmann, R, Rochlitz, C
Publicado 2003